Download PDF
Anästhesiol Intensivmed Notfallmed Schmerzther 2018; 53(02): 102-111
DOI: 10.1055/s-0043-107166
Topthema
CME-Fortbildung
Georg Thieme Verlag KG Stuttgart · New York

ARDS – Ein Update – Teil 1: Epidemiologie, Pathophysiologie und Diagnostik

ARDS – An Update – Part 1: Epidemiology, Pathophysiology and Diagnosis
Rolf Dembinski
,
Frank Mielck
Further Information

Publication History

Publication Date:
09 February 2018 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Das akute Lungenversagen (Acute respiratory Distress Syndrome, ARDS) ist inzwischen seit mehr als 50 Jahren als schwerwiegende Komplikation unterschiedlicher Grunderkrankungen gefürchtet [1]. Häufig leiden ARDS-Patienten langfristig unter schwerwiegenden Beeinträchtigungen – auch nach primär erfolgreicher Therapie. Der erste Teil dieses Updates gibt einen aktualisierten Überblick zu Definition, Epidemiologie und Pathophysiologie des ARDS.

Abstract

The Acute Respiratory Distress Syndrome (ARDS) is defined by hypoxemic respiratory failure caused by inflammatory response within the lung usually requiring invasive mechanical ventilation. Despite more than 50 years of research numerous issues regarding epidemiology, pathophysiology and diagnosis remain unclear until today: Due to rather unspecific clinical diagnostic criteria incidence of ARDS varies considerably in clinical trials with a range from 4 to 79 cases per 100 000 persons per year. Consequently, mortality is also highly variable from about 40 to 60% in severe ARDS. Pathophysiology is mainly characterized by granulocyte infiltration of the lung thereby inducing interstitial and intra-alveolar lung edema with surfactant depletion and atelectasis formation. However, it is unknown whether pulmonary and extrapulmonary causes and risk factors for ARDS are accompanied by different pathophysiologic processes due to primary endothelial and epithelial injury. Thus, possible benefits of corresponding biomarker panels for the differentiation of endothelial and epithelial lung injury are also speculative until today. Therefore, ARDS diagnosis is still based on clinical findings and radiological imaging.

Kernaussagen

  • Das akute Lungenversagen ist ein klinisch definiertes Syndrom unterschiedlicher Genese.

  • Aufgrund der unspezifischen Definitionskriterien variieren epidemiologische Angaben zum Teil erheblich: So rangiert die Inzidenz zwischen 4 und 79 Fällen pro 100000 Einwohner und Jahr, während die Letalität etwa zwischen 40 und 60% liegt.

  • Die Pathophysiologie ist durch eine granulozytäre Inflammationsreaktion in der Lunge mit nachfolgendem interstitiellem und intraalveolärem Lungenödem mit Surfactant-Mangel und Atelektasenbildung gekennzeichnet.

  • Inwieweit auslösende Faktoren entsprechend ihrem primär endothelialen oder epithelialen Schädigungsmechanismus den pathophysiologischen Prozess und den Krankheitsverlauf beeinflussen, ist bis heute ungeklärt.

  • Noch sind keine Biomarker zur Diagnose oder spezifischen Therapie etabliert.

  • Die Diagnostik fußt auf klinischen Befunden und radiologischer Bildgebung.

Schlüsselwörter

akute respiratorische Insuffizienz - Hypoxämie - Inflammation - Inzidenz - Letalität

Key words

acute respiratory failure - hypoxemia - inflammation - incidence - mortality
 

  • Literatur

  • 1 Slutsky AS, Villar J, Pesenti A. Happy 50th birthday ARDS!. Intensive Care Med 2016; 42: 637-639
    CrossrefPubMedGoogle Scholar
  • 2 Ashbaugh DG, Bigelow DB, Petty TL. et al. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. The Lancet, Saturday 12 August 1967. Crit Care Resusc 2005; 7: 60-61
    PubMedGoogle Scholar
  • 3 Murray JF, Matthay MA, Luce JM. et al. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138: 720-723
    CrossrefPubMedGoogle Scholar
  • 4 Bernard GR, Artigas A, Brigham KL. et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824
    CrossrefPubMedGoogle Scholar
  • 5 Ranieri VM, Rubenfeld GD, Thompson BT. et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012; 307: 2526-2533
    CrossrefPubMedGoogle Scholar
  • 6 Villar J, Perez-Mendez L, Kacmarek RM. The Berlin definition met our needs: no. Intensive Care Med 2016; 42: 648-650
    CrossrefPubMedGoogle Scholar
  • 7 Pham T, Rubenfeld GD. Fifty years of research in ARDS. The epidemiology of acute respiratory distress syndrome. A 50th birthday review. Am J Respir Crit Care Med 2017; 195: 860-870
    CrossrefPubMedGoogle Scholar
  • 8 Rice TW, Wheeler AP, Bernard GR. et al. Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS. Chest 2007; 132: 410-417
    CrossrefPubMedGoogle Scholar
  • 9 Bass CM, Sajed DR, Adedipe AA. et al. Pulmonary ultrasound and pulse oximetry versus chest radiography and arterial blood gas analysis for the diagnosis of acute respiratory distress syndrome: a pilot study. Crit Care 2015; 19: 282
    CrossrefPubMedGoogle Scholar
  • 10 Bellani G, Laffey JG, Pham T. et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016; 315: 788-800
    CrossrefPubMedGoogle Scholar
  • 11 Rubenfeld GD, Caldwell E, Peabody E. et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353: 1685-1693
    CrossrefPubMedGoogle Scholar
  • 12 Bersten AD, Edibam C, Hunt T. et al. Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian States. Am J Respir Crit Care Med 2002; 165: 443-448
    CrossrefPubMedGoogle Scholar
  • 13 Luhr OR, Antonsen K, Karlsson M. et al. Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. The ARF Study Group. Am J Respir Crit Care Med 1999; 159: 1849-1861
    CrossrefPubMedGoogle Scholar
  • 14 Li G, Malinchoc M, Cartin-Ceba R. et al. Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med 2011; 183: 59-66
    CrossrefPubMedGoogle Scholar
  • 15 Sigurdsson MI, Sigvaldason K, Gunnarsson TS. et al. Acute respiratory distress syndrome: nationwide changes in incidence, treatment and mortality over 23 years. Acta Anaesthesiol Scand 2013; 57: 37-45
    CrossrefPubMedGoogle Scholar
  • 16 Manzano F, Yuste E, Colmenero M. et al. Incidence of acute respiratory distress syndrome and its relation to age. J Crit Care 2005; 20: 274-280
    CrossrefPubMedGoogle Scholar
  • 17 Erickson SE, Shlipak MG, Martin GS. et al. Racial and ethnic disparities in mortality from acute lung injury. Crit Care Med 2009; 37: 1-6
    CrossrefPubMedGoogle Scholar
  • 18 Meyer NJ, Christie JD. Genetic heterogeneity and risk of acute respiratory distress syndrome. Semin Respir Crit Care Med 2013; 34: 459-474
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Reilly JP, Christie JD, Meyer NJ. Fifty years of research in ARDS. Genomic contributions and opportunities. Am J Respir Crit Care Med 2017; 196: 1113-1121
    CrossrefPubMedGoogle Scholar
  • 20 Suchyta MR, Clemmer TP, Elliott CG. et al. The adult respiratory distress syndrome. A report of survival and modifying factors. Chest 1992; 101: 1074-1079
    CrossrefPubMedGoogle Scholar
  • 21 Raymondos K, Dirks T, Quintel M. et al. Outcome of acute respiratory distress syndrome in university and non-university hospitals in Germany. Crit Care 2017; 21: 122
    CrossrefPubMedGoogle Scholar
  • 22 Castillo RL, Carrasco Loza R, Romero-Dapueto C. Pathophysiological approaches of acute respiratory distress syndrome: novel bases for study of lung injury. Open Respir Med J 2015; 9: 83-91
    CrossrefPubMedGoogle Scholar
  • 23 Millar FR, Summers C, Griffiths MJ. et al. The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities. Thorax 2016; 71: 462-473
    CrossrefPubMedGoogle Scholar
  • 24 Radermacher P, Maggiore SM, Mercat A. Fifty years of research in ARDS. Gas exchange in acute respiratory distress syndrome. Am J Respir Crit Care Med 2017; 196: 964-984
    CrossrefPubMedGoogle Scholar
  • 25 Gattinoni L, Marini JJ, Pesenti A. et al. The “baby lung” became an adult. Intensive Care Med 2016; 42: 663-673
    CrossrefPubMedGoogle Scholar
  • 26 Blondonnet R, Constantin JM, Sapin V. et al. A Pathophysiologic approach to biomarkers in acute respiratory distress syndrome. Dis Markers 2016; 2016: 3501373
    PubMedGoogle Scholar
  • 27 Zochios V, Parhar K, Tunnicliffe W. et al. The right ventricle in ARDS. Chest 2017; 152: 181-193
    CrossrefPubMedGoogle Scholar
  • 28 Aikawa N, Kawasaki Y. Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of acute respiratory distress syndrome. Ther Clin Risk Manag 2014; 10: 621-629
    PubMedGoogle Scholar
  • 29 Rice WG, Weiss SJ. Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor. Science 1990; 249: 178-181
    CrossrefPubMedGoogle Scholar
  • 30 Wang T, Zhu Z, Liu Z. et al. Plasma neutrophil elastase and elafin as prognostic biomarker for acute respiratory distress syndrome: a multicenter survival and longitudinal prospective observation study. Shock 2017; 48: 168-174
    CrossrefPubMedGoogle Scholar
  • 31 Gattinoni L, Caironi P, Cressoni M. et al. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 2006; 354: 1775-1786
    CrossrefPubMedGoogle Scholar
  • 32 Calfee CS, Ware LB, Eisner MD. et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008; 63: 1083-1089
    CrossrefPubMedGoogle Scholar
  • 33 Ware LB, Calfee CS. Biomarkers of ARDS: whatʼs new?. Intensive Care Med 2016; 42: 797-799
    CrossrefPubMedGoogle Scholar
  • 34 Mekontso Dessap A, Ware LB, Bagshaw SM. How could biomarkers of ARDS and AKI drive clinical strategies?. Intensive Care Med 2016; 42: 800-802
    CrossrefPubMedGoogle Scholar
  • 35 Terpstra ML, Aman J, van Nieuw Amerongen GP. et al. Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 2014; 42: 691-700
    CrossrefPubMedGoogle Scholar
  • 36 Ware LB, Koyama T, Billheimer DD. et al. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 2010; 137: 288-296
    CrossrefPubMedGoogle Scholar
  • 37 Mekontso Dessap A, Boissier F, Charron C. et al. Acute cor pulmonale during protective ventilation for acute respiratory distress syndrome: prevalence, predictors, and clinical impact. Intensive Care Med 2016; 42: 862-870
    CrossrefPubMedGoogle Scholar
  • 38 Brochard L, Pham T, Rubenfeld G. Does my patient really have ARDS?. Intensive Care Med 2016; 42: 656-658
    CrossrefPubMedGoogle Scholar
  • 39 Umbrello M, Formenti P, Bolgiaghi L. et al. Current concepts of ARDS: a narrative review. Int J Mol Sci 2016; 18: pii:E64
    CrossrefPubMedGoogle Scholar
  • 40 Papazian L, Calfee CS, Chiumello D. et al. Diagnostic workup for ARDS patients. Intensive Care Med 2016; 42: 674-685
    CrossrefPubMedGoogle Scholar
  • 41 Pesenti A, Musch G, Lichtenstein D. et al. Imaging in acute respiratory distress syndrome. Intensive Care Med 2016; 42: 686-698
    CrossrefPubMedGoogle Scholar
  • 42 Mongodi S, Bouhemad B, Iotti GA. et al. An ultrasonographic sign of intrapulmonary shunt. Intensive Care Med 2016; 42: 912-913
    CrossrefPubMedGoogle Scholar
  • 43 Hsu CF, Cheng JS, Lin WC. et al. Electrical impedance tomography monitoring in acute respiratory distress syndrome patients with mechanical ventilation during prolonged positive end-expiratory pressure adjustments. J Formos Med Assoc 2016; 115: 195-202
    CrossrefPubMedGoogle Scholar
  • 44 Vieillard-Baron A, Matthay M, Teboul JL. et al. Expertsʼ opinion on management of hemodynamics in ARDS patients: focus on the effects of mechanical ventilation. Intensive Care Med 2016; 42: 739-749
    CrossrefPubMedGoogle Scholar